3 \u0399\u03bf\u03c5\u03bd\u03af\u03bf\u03c5 2016<\/p>\n

\u03a3\u03c4\u03b9\u03c2 3 \u0399\u03bf\u03c5\u03bd\u03af\u03bf\u03c5, \u03c4\u03bf \u038a\u03b4\u03c1\u03c5\u03bc\u03b1 \u03b1\u03bd\u03b1\u03ba\u03bf\u03af\u03bd\u03c9\u03c3\u03b5 \u03c4\u03bf\u03c5\u03c2 \u03bd\u03b9\u03ba\u03b7\u03c4\u03ad\u03c2 \u03c4\u03c9\u03bd Prix Galien \u0392\u03b5\u03bb\u03b3\u03af\u03bf\u03c5 \u03b3\u03b9\u03b1 \u03c4\u03bf 2016 \u03c9\u03c2 \u03b1\u03ba\u03bf\u03bb\u03bf\u03cd\u03b8\u03c9\u03c2:<\/p>\n

\n
• Connexin hemichannels \u03b3\u03b9\u03b1 \u03c4\u03b1 \u03b5\u03b3\u03ba\u03b5\u03c6\u03b1\u03bb\u03b9\u03ba\u03ac \u03ba\u03b1\u03b9 \u03c4\u03b1 \u03ba\u03b1\u03c1\u03b4\u03b9\u03b1\u03b3\u03b3\u03b5\u03b9\u03b1\u03ba\u03ac \u03bd\u03bf\u03c3\u03ae\u03bc\u03b1\u03c4\u03b1<\/li>\n
• Dr De Bock Marijke<\/strong>, Dr Decrock Elke<\/strong>\u00a0\u03ba\u03b1\u03b9 Dr Wang Nan<\/strong> \u2013 Universiteit Gent<\/li>\n
• Nivolumab, OPDIVO<\/strong>\u00ae, BMS<\/strong> Belgium & Luxembourg<\/li>\n
• Pembrolizumab KEYTRUDA<\/strong>\u00ae MSD<\/strong> Belgium and Luxembourg<\/li>\n
• S-ICD EMBLEM Pierre Chauvineau<\/strong> Vice President Rhythm Management EMEA, Boston Scientific<\/strong><\/li>\n<\/ul>\n

  \u0397 \u03c4\u03b5\u03bb\u03b5\u03c4\u03ae \u03b2\u03c1\u03ac\u03b2\u03b5\u03c5\u03c3\u03b7\u03c2 \u03c0\u03c1\u03b1\u03b3\u03bc\u03b1\u03c4\u03bf\u03c0\u03bf\u03b9\u03ae\u03b8\u03b7\u03ba\u03b5 \u03c3\u03c4\u03bf BOZAR, \u03c5\u03c0\u03cc \u03c4\u03b7\u03bd \u03c0\u03c1\u03bf\u03b5\u03b4\u03c1\u03af\u03b1 \u03c4\u03bf\u03c5 M. Kris Peeters<\/strong>, \u0391\u03bd\u03b1\u03c0\u03bb\u03b7\u03c1\u03c9\u03c4\u03ae \u03a0\u03c1\u03c9\u03b8\u03c5\u03c0\u03bf\u03c5\u03c1\u03b3\u03bf\u03cd \u03ba\u03b1\u03b9 \u03a5\u03c0\u03bf\u03c5\u03c1\u03b3\u03bf\u03cd \u0391\u03c0\u03b1\u03c3\u03c7\u03cc\u03bb\u03b7\u03c3\u03b7\u03c2, \u039f\u03b9\u03ba\u03bf\u03bd\u03bf\u03bc\u03af\u03b1\u03c2 \u03ba\u03b1\u03b9 \u039a\u03b1\u03c4\u03b1\u03bd\u03b1\u03bb\u03c9\u03c4\u03ce\u03bd \u03b3\u03b9\u03b1 \u03c4\u03bf \u0395\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u0395\u03bc\u03c0\u03cc\u03c1\u03b9\u03bf. \u039f Jo De Cock<\/strong>, \u0393\u03b5\u03bd\u03b9\u03ba\u03cc\u03c2 \u0394\u03b9\u03b5\u03c5\u03b8\u03c5\u03bd\u03c4\u03ae\u03c2 \u03c4\u03bf\u03c5 \u0395\u03b8\u03bd\u03b9\u03ba\u03bf\u03cd \u0399\u03bd\u03c3\u03c4\u03b9\u03c4\u03bf\u03cd\u03c4\u03bf\u03c5 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03a5\u03b3\u03b5\u03af\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd \u0391\u03c3\u03c6\u03ac\u03bb\u03b9\u03c3\u03b7, \u03c0\u03b1\u03c1\u03ad\u03c3\u03c4\u03b7 \u03bc\u03b5\u03c4\u03b1\u03be\u03cd \u03ac\u03bb\u03bb\u03c9\u03bd \u03c3\u03c4\u03b7\u03bd \u03c4\u03b5\u03bb\u03b5\u03c4\u03ae \u03b1\u03c0\u03bf\u03bd\u03bf\u03bc\u03ae\u03c2.<\/p>\n

  \u0393\u03b9\u03b1 \u03c0\u03b5\u03c1\u03b9\u03c3\u03c3\u03cc\u03c4\u03b5\u03c1\u03b5\u03c2 \u03c0\u03bb\u03b7\u03c1\u03bf\u03c6\u03bf\u03c1\u03af\u03b5\u03c2, \u03bc\u03c0\u03bf\u03c1\u03b5\u03af\u03c4\u03b5 \u03bd\u03b1 \u03b5\u03c0\u03b9\u03ba\u03bf\u03b9\u03bd\u03c9\u03bd\u03ae\u03c3\u03b5\u03c4\u03b5 \u03bc\u03b5 \u03c4\u03b7\u03bd \u03ba\u03b1 Isabelle SPETTANTE \u03c3\u03c4\u03bf mail isabelle.spettante@roularta.be<\/a>, \u03ae \u03bd\u03b1 \u03b5\u03c0\u03b9\u03c3\u03ba\u03b5\u03c5\u03b8\u03b5\u03af\u03c4\u03b5 \u03c4\u03b7\u03bd \u03b9\u03c3\u03c4\u03bf\u03c3\u03b5\u03bb\u03af\u03b4\u03b1 www.prixgalien-galenusprijs.be<\/a><\/p>\n

  \u039c\u03c0\u03bf\u03c1\u03b5\u03af\u03c4\u03b5\u00a0\u03bd\u03b1 \u03b1\u03c0\u03bf\u03bb\u03b1\u03cd\u03c3\u03b5\u03c4\u03b5 \u03c3\u03c4\u03b9\u03b3\u03bc\u03ad\u03c2 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u00a0\u03c4\u03b5\u03bb\u03b5\u03c4\u03ae \u03b1\u03c0\u03bf\u03bd\u03bf\u03bc\u03ae\u03c2 \u03c4\u03c9\u03bd \u03b2\u03c1\u03b1\u03b2\u03b5\u03af\u03c9\u03bd Prix Galien Belgium, \u03ba\u03ac\u03bd\u03bf\u03bd\u03c4\u03b1\u03c2 \u03ba\u03bb\u03b9\u03ba \u03c3\u03c4\u03b1 \u03b1\u03ba\u03cc\u03bb\u03bf\u03c5\u03b8\u03b1 \u03b2\u03af\u03bd\u03c4\u03b5\u03bf:<\/p>\n